ММВБ 3 948 -0,3%  Nasdaq 15 381 0,8%  Биткойн 56 337 -0,2%  USD/RUB 73,8112 0,3% 
РТС 1 690 0,2%  S&P500 4 577 1,4%  Нефть 70,8 0,5%  EUR/RUB 83,3655 0,3% 
Dow 34 640 1,8%  FTSE100 7 129 -0,6%  Золото 1 773 0,3%  EUR/USD 1,1293 -0,1% 

Crinetics Pharmaceuticals Inc Registered Shs - Профиль

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.


Название Доля (%)
Fidelity Management & Research Co. LLC11,02
Perceptive Advisors LLC10,28
Driehaus Capital Management LLC7,78
OrbiMed Advisors Private Equity7,77
OrbiMed Advisors LLC7,77
Deep Track Capital LP5,05
Bain Capital Life Sciences LP4,36
Bain Capital Life Sciences Investors LLC4,36
Vanguard Group, Inc. (Subfiler)4,14
BlackRock Fund Advisors3,97
5AM Venture Management LLC3,53
5AM Venture Management LLC3,53
State Street Corp.2,89
Ecor1 Capital LLC2,62




Добавить или редактировать инструмент